Nalu Bio Adds Top CPG Talent, Dondeena Bradley, to Board to Drive Adoption of No-High, Chemistry-Derived Cannabinoids for Health and Wellness

Appointment Targets Innovation for Fortune 500 Health and Wellness Companies

While Helping to Close the Women’s Wellness Gap—a $1 Trillion Opportunity

SAN FRANCISCO, Feb. 29, 2024 /PRNewswire/ — Nalu Bio, a biotech company that is expanding health and wellness solutions through the development of no-high, chemistry-derived cannabinoid CPG ingredients, products, and therapeutic applications, proudly announces the appointment of Dondeena Bradley to its board of directors. With a distinguished career guiding health and wellness strategy, research and development, and wellbeing and nutrition-based innovations for the top global CPG companies, Dondeena brings invaluable expertise to drive an industry shift comparable to the introduction of vitamins 70 years ago—all while while closing the women’s wellness gap—a $1 trillion opportunity to improve lives and economies globally.1